What makes Watson special? IBM's earlier supercomputers like Deep Blue and Blue Gene (which was actually a series of machines) were powerful for their time, but they were never focused on applications for normal consumers. Watson, with its natural language recognition and ability to sift through mounds of data, is significantly more user friendly. And while we certainly can't call it conscious, it's IBM's most concerted effort in building artificially intelligent supercomputers.
IBM showed off several Watson-powered apps when it opened its new Watson headquarters last year, but today we got a glimpse at a bit more variety. Decibel, a music discovery startup, tapped into the supercomputer's smarts to build MusicGeek, which could put an end to those baffling song recommendations you get from other music services. Go Moment is using Watson for its Rev1 app, which gives hotel staff a way to quickly respond to questions from guests. And Arria NLG has built an app that helps energy companies stay within regulatory guidelines, making it easier for managers to make sense of thousands of pages of legal and technical jargon.
As for those partnerships with cancer institutes, it's yet another part of the company's Watson Health initiative. Watson has been positioned for a while as a boon for doctors when it comes to diagnosis. Just plug in a few symptoms and Watson can bring up plenty of potentially relevant illnesses -- many that even your doctor might not think of. Now Watson's taking that a step further with DNA analysis.
"Determining the right drug combination for an advanced cancer patient is alarmingly difficult, requiring a complex analysis of different sources of Big Data that integrates rapidly emerging clinical trials information with personalized gene sequencing," said Norman Sharpless, director of the University of North Carolina Lineberger Comprehensive Cancer Center, in a statement. "We are partnering with IBM in an effort to solve this decision problem with the help of cognitive technology and to improve the decisions we make with our patients to maximize their chance for cure."
[Photo credit: Michael Nagle/Bloomberg via Getty Images]